Clinical Trial Update: Effect of Desmopressin on Platelet Function in CKD Patients on Antiplatelet Drug [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of desmopressin on platelet function in chronic kidney disease patients on antiplatelet therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Chronic Kidney Disease

Drugs mentioned

• Desmopressin (Desmopressin)

Snippet

Sponsor: University of Ulsan | Conditions: Bleeding, Tachycardia | Phase 1 | Status: COMPLETED